Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: Insights into difference in pathobiology of human retroviruses

Retrovirology

Volumn 9, Issue , 2012, Pages

  Doueiri, Rami ^a   Anupam, Rajaneesh ^a   Kvaratskhelia, Mamuka ^a   Green, Kari B ^a   Lairmore, Michael D ^a,b   Green, Patrick L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14 3 3 PROTEIN EPSILON; ALPHA 1 ANTITRYPSIN; CELL PROTEIN; COFILIN 1; ELONGATION FACTOR TU; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATE ISOMERASE; HEAT SHOCK PROTEIN 90 ALPHA; HEAT SHOCK PROTEIN 90 BETA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HOST PROTEIN; INORGANIC PYROPHOSPHATASE 2; MYOSIN 9; NUCLEAR PROTEIN; PHOSPHOGLYCERATE MUTASE 1; PROFILIN I; PROTEASOME ACTIVATOR COMPLEX SUBUNIT; PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE 5; PROTEIN P28; PROTEIN P30; PROTEOME; RETICULOCALBIN 2; RIBOSOMAL PROTEIN L8; SUCCINATE DEHYDROGENASE (UBIQUINONE); TRANSGELIN 2; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOBLOTTING; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; PERSISTENT VIRUS INFECTION; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RETROVIRUS; SEQUENCE HOMOLOGY; VIRAL TROPISM; VIRUS GENE; VIRUS PATHOGENESIS;

CELL TRANSFORMATION, VIRAL; CHROMATOGRAPHY, AFFINITY; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; PROTEIN INTERACTION MAPPING; PROTEIN-ARGININE N-METHYLTRANSFERASES; RIBONUCLEOPROTEINS; RNA, SMALL INTERFERING; TRANSFECTION; VIRAL CORE PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 84864701579     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-64     Document Type: Article

References (70)

1. Manns A, Blattner WA. The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion 1991, 31:67-75. 10.1046/j.1537-2995.1991.31191096189.x, 1986467.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419. 10.1073/pnas.77.12.7415, 350514, 6261256.
3. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982, 79:2031-2035. 10.1073/pnas.79.6.2031, 346116, 6979048.
4. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, Goto I, Yamamoto N. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993, 196:25-33. 10.1006/viro.1993.1451, 8356797.
5. Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med 2008, 14:429-436. 10.1038/nm1745, 18376405.
6. Yasunaga J, Sakai T, Nosaka K, Etoh K, Tamiya S, Koga S, Mita S, Uchino M, Mitsuya H, Matsuoka M. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 2001, 97:3177-3183. 10.1182/blood.V97.10.3177, 11342446.
7. Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005, 2:16. 10.1186/1742-4690-2-16, 555581, 15743528.
8. Bangham CR, Osame M. Cellular immune response to HTLV-1. Oncogene 2005, 24:6035-6046. 10.1038/sj.onc.1208970, 16155610.
9. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, et al. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology 1997, 48:315-320. 10.1212/WNL.48.2.315, 9040713.
10. Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, Lisinski I, Cushman SW, Jacobson S, Ruscetti FW. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol 2006, 80:8291-8302. 10.1128/JVI.00389-06, 1563841, 16912281.
11. Iacampo S, Cochrane A. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J Virol 1996, 70:8332-8339. 190920, 8970952.
12. Ijichi S, Ramundo MB, Takahashi H, Hall WW. In vivo cellular tropism of human T-cell leukemia virus type II (HTLV-II). J Exp Med 1992, 176:293-296. 10.1084/jem.176.1.293, 2119301, 1351922.
13. Xie L, Green PL. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J Virol 2005, 79:14536-14545. 10.1128/JVI.79.23.14536-14545.2005, 1287554, 16282453.
14. Collins ND, Newbound GC, Ratner L, Lairmore MD. In vitro CD4 + lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1. J Virol 1996, 70:7241-7246. 190781, 8794375.
15. Wang T-G, Ye J, Lairmore M, Green PL. In vitro cellular tropism of human T-cell leukemia virus type 2. AIDS Res Hum Retroviruses 2000, 16:1661-1668. 10.1089/08892220050193119, 11080807.
16. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985. 10.1038/sj.onc.1208978, 16155604.
17. Ross TM, Pettiford SM, Green PL. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol 1996, 70:5194-5202. 190475, 8764028.
18. Feuer G, Green PL. Comparative biology of human T-cell lynphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 2005, 24:5996-6004. 10.1038/sj.onc.1208971, 2659530, 16155606.
19. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard J. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 2002, 76:12813-12822. 10.1128/JVI.76.24.12813-12822.2002, 136662, 12438606.
20. Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, et al. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 2009, 114:2427-2438. 10.1182/blood-2008-09-179879, 2746472, 19602711.
21. Matsuoka M, Green PL. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6:71. 10.1186/1742-4690-6-71, 2731725, 19650892.
22. Nicot C, Dundr JM, Johnson JR, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med 2004, 10:197-201. 10.1038/nm984, 14730358.
23. Zhang W, Nisbet JW, Albrecht B, Ding W, Kashanchi F, Bartoe JT, Lairmore MD. Human T-lymphotropic virus type 1 p30II regulates gene transcription by binding CREB binding protein/p300. J Virol 2001, 75:9885-9895. 10.1128/JVI.75.20.9885-9895.2001, 114560, 11559821.
24. Younis I, Boris-Lawrie K, Green PL. Human T-cell leukemia virus ORF II p28 encodes a post-transcriptional repressor that is recruited at the level of transcription. J Virol 2006, 80:181-191. 10.1128/JVI.80.1.181-191.2006, 1317543, 16352542.
25. Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol 2004, 78:3837-3845. 10.1128/JVI.78.8.3837-3845.2004, 374265, 15047799.
26. Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Washington Parks R, Ferrari MG, et al. Requirement of the human T-cell leukemia virus p12 and p30 genes for infectivity of human dendritic cells and macaques but not rabbits. Blood 2010, 10.1182/blood-2010-05-284141, 3012587, 20733156.
27. Yamamoto B, Li M, Kesic M, Younis I, Lairmore MD, Green PL. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo. Retrovirology 2008, 5:38. 10.1186/1742-4690-5-38, 2405800, 18474092.
28. Robek M, Wong F, Ratner L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol 1998, 72:4458-4462. 109681, 9557741.
29. Koralnik IJ, Fullen J, Franchini G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 1993, 67:2360-2366. 240398, 8445734.
30. Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL. Repression of human T-cell leukemia virus type 1 and 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol 2004, 78:11077-11083. 10.1128/JVI.78.20.11077-11083.2004, 521841, 15452228.
31. Ghorbel S, Sinha-Datta U, Dundr M, Brown M, Franchini G, Nicot C. Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J Biol Chem 2006, 281:37150-37158. 10.1074/jbc.M603981200, 17008317.
32. Sinha-Datta U, Datta A, Ghorbel S, Dodon MD, Nicot C. Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication. J Biol Chem 2007, 282:14608-14615. 10.1074/jbc.M611219200, 17360706.
33. Michael B, Nair AM, Hiraragi H, Shen L, Feuer G, Boris-Lawrie K, Lairmore MD. Human T lymphotropic virus type 1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 2004, 1:39. 10.1186/1742-4690-1-39, 538277, 15560845.
34. Taylor JM, Ghorbel S, Nicot C. Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. BMC Genomics 2009, 10:311. 10.1186/1471-2164-10-311, 2723137, 19602286.
35. Datta A, Silverman L, Phipps AJ, Hiraragi H, Ratner L, Lairmore MD. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival. Retrovirology 2007, 4:49. 10.1186/1742-4690-4-49, 1937004, 17634129.
36. Baydoun HH, Pancewicz J, Bai X, Nicot C. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol Canc 2010, 9:302.
37. Anupam R, Datta A, Kesic M, Green-Church K, Shkriabai N, Kvaratskhelia M, Lairmore MD. Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival. J Biol Chem 2011, 286:7661-7668. 10.1074/jbc.M110.176354, 3045020, 21216954.
38. Awasthi S, Sharma A, Wong K, Zhang J, Matlock EF, Rogers L, Motloch P, Takemoto S, Taguchi H, Cole MD, et al. A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions. Mol Cell Biol 2005, 25:6178-6198. 10.1128/MCB.25.14.6178-6198.2005, 1168837, 15988028.
39. Baydoun HH, Pancewicz J, Nicot C. Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood 2011, 117:5897-5906. 10.1182/blood-2010-08-304600, 3112037, 21427292.
40. Barrios CS, Abuerreish M, Lairmore MD, Castillo L, Giam CZ, Beilke MA. Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells. Viral Immunol 2011, 24:429-439. 10.1089/vim.2011.0037, 22111594.
41. Bertazzoni U, Turci M, Avesani F, Di Gennaro G, Bidoia C, Romanelli MG. Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences. Viruses 2011, 3:541-560. 10.3390/v3050541, 3185761, 21994745.
42. Higuchi M, Fujii M. Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 2009, 6:117. 10.1186/1742-4690-6-117, 2806368, 20017952.
43. Raines RT, McCormick M, Van Oosbree TR, Mierendorf RC. The S. Tag fusion system for protein purification. Methods Enzymol 2000, 326:362-376.
44. Nishioka K, Reinberg D. Methods and tips for the purification of human histone methyltransferases. Methods 2003, 31:49-58. 10.1016/S1046-2023(03)00087-2, 12893173.
45. Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, et al. Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology 2012, 9:26. 10.1186/1742-4690-9-26, 3351729, 22458338.
46. Lairmore MD, Anupam R, Bowden N, Haines R, Haynes RA, Ratner L, Green PL. Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses 2011, 3:1131-1165. 10.3390/v3071131, 3185783, 21994774.
47. Michael B, Nair AM, Datta A, Hiraragi H, Ratner L, Lairmore MD. Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. Virology 2006, 354:225-239. 10.1016/j.virol.2006.07.002, 3044896, 16890266.
48. Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 2005, 15:27-33. 10.1016/j.tcb.2004.11.003, 15653075.
49. Li X, Amazit L, Long W, Lonard DM, Monaco JJ, O'Malley BW. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007, 26:831-842. 10.1016/j.molcel.2007.05.028, 17588518.
50. Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007, 26:843-852. 10.1016/j.molcel.2007.05.022, 2031223, 17588519.
51. Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J 2008, 27:852-864. 10.1038/emboj.2008.25, 2265109, 18309296.
52. Li X, Lonard DM, Jung SY, Malovannaya A, Feng Q, Qin J, Tsai SY, Tsai MJ, O'Malley BW. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 2006, 124:381-392. 10.1016/j.cell.2005.11.037, 16439211.
53. Barnikol-Watanabe S, Gross NA, Gotz H, Henkel T, Karabinos A, Kratzin H, Barnikol HU, Hilschmann N. Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein. Biol Chem Hoppe Seyler 1994, 375:497-512. 10.1515/bchm3.1994.375.8.497, 7811391.
54. Nesselhut J, Jurgan U, Onken E, Gotz H, Barnikol HU, Hirschfeld G, Barnikol-Watanabe S, Hilschmann N. Golgi retention of human protein NEFA is mediated by its N-terminal Leu/Ile-rich region. FEBS Lett 2001, 509:469-475. 10.1016/S0014-5793(01)03187-8, 11749975.
55. Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S. Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep 2000, 1:287-292. 10.1093/embo-reports/kvd058, 1083732, 11256614.
56. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007, 7:690-702. 10.1038/nri2152, 17703229.
57. Paul S, Dansithong W, Kim D, Rossi J, Webster NJ, Comai L, Reddy S. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J 2006, 25:4271-4283. 10.1038/sj.emboj.7601296, 1570429, 16946708.
58. Zhang Y, Lindblom T, Chang A, Sudol M, Sluder AE, Golemis EA. Evidence that dim1 associates with proteins involved in pre-mRNA splicing, and delineation of residues essential for dim1 interactions with hnRNP F and Npw38/PQBP-1. Gene 2000, 257:33-43. 10.1016/S0378-1119(00)00372-3, 11054566.
59. Ostrowski J, Van Seuningen I, Seger R, Rauch CT, Sleath PR, McMullen BA, Bomsztyk K. Purification, cloning, and expression of a murine phosphoprotein that binds the kappa B motif in vitro identifies it as the homolog of the human heterogeneous nuclear ribonucleoprotein K protein. Description of a novel DNA-dependent phosphorylation process. J Biol Chem 1994, 269:17626-17634.
60. Di Lorenzo A, Bedford MT. Histone arginine methylation. FEBS Lett 2011, 585:2024-2031. 10.1016/j.febslet.2010.11.010, 3409563, 21074527.
61. Wang L, Pal S, Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol 2008, 28:6262-6277. 10.1128/MCB.00923-08, 2577430, 18694959.
62. Hou Z, Peng H, Ayyanathan K, Yan KP, Langer EM, Longmore GD, Rauscher FJ. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 2008, 28:3198-3207. 10.1128/MCB.01435-07, 2423142, 18347060.
63. Tabata T, Kokura K, Ten Dijke P, Ishii S. Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells 2009, 14:17-28. 10.1111/j.1365-2443.2008.01246.x, 19032343.
64. Cesaro E, De Cegli R, Medugno L, Florio F, Grosso M, Lupo A, Izzo P, Costanzo P. The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene. J Biol Chem 2009, 284:32321-32330. 10.1074/jbc.M109.043349, 2781646, 19741270.
65. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004, 24:9630-9645. 10.1128/MCB.24.21.9630-9645.2004, 522266, 15485929.
66. Lacroix M, El Messaoudi S, Rodier G, Le Cam A, Sardet C, Fabbrizio E. The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep 2008, 9:452-458. 10.1038/embor.2008.45, 2373370, 18404153.
67. Scoumanne A, Zhang J, Chen X. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function. Nucleic Acids Res 2009, 37:4965-4976. 10.1093/nar/gkp516, 2731901, 19528079.
68. Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B, La Thangue NB. Arginine methylation regulates the p53 response. Nat Cell Biol 2008, 10:1431-1439. 10.1038/ncb1802, 19011621.
69. Martin G, Ostareck-Lederer A, Chari A, Neuenkirchen N, Dettwiler S, Blank D, Ruegsegger U, Fischer U, Keller W. Arginine methylation in subunits of mammalian pre-mRNA cleavage factor I. RNA 2010, 16:1646-1659. 10.1261/rna.2164210, 2905762, 20562214.
70. Neuenkirchen N, Chari A, Fischer U. Deciphering the assembly pathway of Sm-class U snRNPs. FEBS Lett 2008, 582:1997-2003. 10.1016/j.febslet.2008.03.009, 18348870.